Genelux

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Genelux Corp

News

Management

Press Releases

Genelux Corporation Announces New Chief Financial Officer

General

Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease

Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

Earnings

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

Health Care

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

GNLX

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Avalo Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Crescent Biopharma

Compugen

Coherus Oncology

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Elicio Therapeutics

Fate Therapeutics

Forte Biosciences

Foghorn Therapeutics

Genfit

Heron Therapeutics

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

Pyxis Oncology

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tonix Pharmaceuticals Holding Corp. - Common Stock

Comments

Genelux

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO